Article
[Gene therapy treatment based on an ophthalmic indication in hereditary retinal dystrophy caused by RPE65 biallelic gene mutation.]
Orvosi hetilap - 27 Nov 2022
Vizvári Eszter, Smeller Lilla, Jánossy Ágnes, Lőrincz Máté, Janáky Márta, Tóth-Molnár Edit
Abstract excerpt
INTRODUCTION: Leber's congenital amaurosis is a genetically determined disease belonging to the group of hereditary retinal dystrophies that leads to significant visual impairment in childhood. The disease initially causes a concentric narrowing of the visual field and, with time, loss of central vision. The RPE65 gene mutation-related retinal dystrophy is the first ophthalmic disease for which gene therapy is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
